Atropos Health furthers commitment to Oncology with addition of Ontada data

Read the release
Learn more
Logo
  • Solutions
        • Health Systems
          • Pharmacy
          • Research Informatics
          • Value Based Care / Quality
          • GME
        • Life Sciences
          • Brand Analytics
          • Precision Medicine AI/ML
          • HEOR, Medical Affairs & RWE
          • Research & Development
  • Technology
        • Platform
          • GENEVA OS™
        • Evidence Generation Tools
          • ChatRWD®
          • Green Button™
          • Alexandria™
          • Forge™
        • Data
          • Atropos Evidence™ Network
          • Data Quality Scoring
  • About
    • About Us
    • Careers
  • Resources
    • Resource Center
    • Publications
    • Customer Stories
    • News & Media
    • Press Releases
  • Contact Us
  • Login
Specialists discuss concerns over impact of semaglutide on the eye

Specialists discuss concerns over impact of semaglutide on the eye

by Julia Rudo | Nov 8, 2024 | News and Media

“In a letter to the editor published in the Journal of Diabetes Science and Technology, David C. Klonoff, MD, medical director of the Diabetes Research Institute at Mills-Peninsula Medical Center in San Mateo, California, noted that the findings of the Hathaway...
Forbes: Atropos Health helps doctors, pharma companies and insurers figure out how patients react to treatments in the real-world

Forbes: Atropos Health helps doctors, pharma companies and insurers figure out how patients react to treatments in the real-world

by Maria Hernandez | May 23, 2024 | News and Media

Katie Jennings of Forbes sat down with Dr. Brigham Hyde, CEO and co-Founder of Atropos Health to discuss the $33M Series B fundraise.See the full article here:...
Becker’s Hospital Review: Weight Loss Drugs and Surgery Complications: New study

Becker’s Hospital Review: Weight Loss Drugs and Surgery Complications: New study

by Maria Hernandez | May 14, 2024 | News and Media

Paige Twenter of Becker’s Hospital Review covered a new study in Diabetes, Obesity, and Metabolism led by Dr. David Klonoff, a member of the Atropos Health Clinical Advisory Board.The study included an analysis of 130 million patient records. Researchers evaluated...
Diabetes, Obesity and Metabolism Publishes “Risks of Peri- and Post-Operative Complications with Glucagon-like Peptide-1 Receptor Agonists”

Diabetes, Obesity and Metabolism Publishes “Risks of Peri- and Post-Operative Complications with Glucagon-like Peptide-1 Receptor Agonists”

by Maria Hernandez | May 14, 2024 | News and Media, Publications

On May 14, 2024, the Diabetes, Obesity and Metabolism published “Risks of Peri- and Post-Operative Complications With Glucagon-like Peptide-1 Receptor Agonists” by Klonoff, David; Diabetes Research Institute,  Kim, Sun; Stanford University School of Medicine, Galindo,...
DiviWP Logo
  • Follow
  • Follow

Solutions

Health Systems

Pharmacy

Research Informatics

Value Based Care / Quality

GME

Life Sciences

Brand Analytics

Precision Medicine AI/ML

HEOR, Medical Affairs & RWE

Research & Development

Technology

Platform

GENEVA OS™

Evidence Generation Tools

ChatRWD®

Green Button™

Alexandria™

Forge™

Data

Atropos Evidence™ Network

Data Quality Scoring

About

  • About Us
  • Careers

Resources

  • Resources Center
  • Publications
  • Customer Stories
  • News & Media
  • Press Releases

Copyright © 2024 Atropos Health. All Rights Reserved | Privacy Policy | Ethics Report | Terms of Service

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}